• 1
    Cunha F.Q., Poole S., Lorenzetti B.B., Ferreira S.H. (1992) The pivotal role of tumour necrosis factor alpha in the development of inflammatory hyperalgesia. Br J Pharmacol;107:660664.
  • 2
    Woolf C.J., Allchorne A., Safieh-Garabedian B., Poole S. (1997) Cytokines, nerve growth factor and inflammatory hyperalgesia: the contribution of tumour necrosis factor alpha. Br J Pharmacol;121:417424.
  • 3
    Shubayev V.I., Myers R.R. (2000) Upregulation and interaction of TNF alpha and gelatinases A and B in painful peripheral nerve injury. Brain Res;855:8389.
  • 4
    Wagner R., Myers R.R. (1996) Schwann cells produce tumor necrosis factor alpha: expression in injured and non-injured nerves. Neuroscience;73:625629.
  • 5
    Ignatowski T.A., Covey W.C., Knight P.R., Severin C.M., Nickola T.J., Spengler R.N. (1999) Brain-derived TNF alpha mediates neuropathic pain. Brain Res;841:7077.
  • 6
    Padi S.S.V., Kulkarni S.K. (2008) Minocycline prevents the development of neuropathic pain, but not acute pain: possible anti-inflammatory and antioxidant mechanisms. Eur J Pharmacol;601:7987.
  • 7
    Naik A.K., Tandan S.K., Dudhgaonkar S.P., Jadhav S.H., Kataria M., Prakash V.R., Kumar D. (2006) Role of oxidative stress in pathophysiology of peripheral neuropathy and modulation by N-acetyl-l-cysteine in rats. Eur J Pain;10:573579.
  • 8
    Levy D., Hoke A., Zochodne D.W. (1999) Local expression of inducible nitric oxide synthase in an animal model of neuropathic pain. Neurosci Lett;260:207209.
  • 9
    Sommer C., Marziniak M., Myers R.R. (1998) The effect of thalidomide treatment on vascular pathology and hyperalgesia caused by chronic constriction injury of rat nerve. Pain;74:8391.
  • 10
    Sommer C., Lindenlaub T., Teuteberg P., Schäfers M., Hartung T., Toyka K.V. (2001) Anti-TNF-neutralizing antibodies reduce pain-related behavior in two different mouse models of painful mononeuropathy. Brain Res;913:8689.
  • 11
    Salgin-Gökşen U., Gökhan-Kelekçi N., Göktaş O., Köysal Y., Kiliç E., Işik S., Aktay G., Ozalp M. (2007) 1-Acylthiosemicarbazides, 1,2,4-triazole-5(4H)-thiones, 1,3,4-thiadiazoles and hydrazones containing 5-methyl-2-benzoxazolinones: synthesis, analgesic-anti-inflammatory and antimicrobial activities. Bioorg Med Chem;15:57385751.
  • 12
    Mir I., Siddiqui M.T., Comrie A. (1970) Antituberculosis agents. I. Alpha-(5-(2-Furyl)-1,2,4-triazol-3-ylthio) acethydrazide and related compounds. Tetrahedron;26:52355238.
  • 13
    Modzelewska-Banachiewicz B., Banachiewicz J., Chodkowska A., Jagiełło-Wójtowicz E., Mazur L. (2004) Synthesis and biological activity of new derivatives of 3-(3,4-diaryl-1,2,4-triazole-5-yl)propenoic acid. Eur J Med Chem;39:873877.
  • 14
    Tozkoparan B., Aktay G., Yesilada E. (2002) Synthesis of some 1,2,4-triazolo[3,2-b]-1,3-thiazine-7-ones with potential analgesic and antiinflammatory activities. Farmaco;57:145152.
  • 15
    Navidpour L., Shafaroodi H., Abdi K., Amini M., Ghahremani M.H., Dehpour A.R., Shafiee A. (2006) Design, synthesis, and biological evaluation of substituted 3-alkylthio-4,5-diaryl-4H-1,2,4-triazoles as selective COX-2 inhibitors. Bioorg Med Chem;14:25072517.
  • 16
    Shalini M., Yogeeswari P., Sriram D., Stables J.P. (2009) Cyclization of the semicarbazone template of aryl semicarbazones: synthesis and anticonvulsant activity of 4,5-diphenyl-2H-1,2,4-triazol-3(4H)-one. Biomed Pharmacother;63:187193.
  • 17
    Carroll W.A., Kalvin D.M., Perez Medrano A., Floriancic A.S., Wang Y., Donnelly-Roberts D.L., Namovic M.T., Grayson G., Honore P., Jarvis M.F. (2007) Novel and potent 3-(2,3-dichlorophenyl)-4-(benzyl)-4H-1,2,4-triazole P2X7 antagonists. Bioorg Med Chem Lett;17:40444048.
  • 18
    Floriancic A.S., Peddi S., Perez Medrano A., Li B., Namovic M.T., Grayson G., Donnelly-Roberts D.L., Jarvis M.F., Carroll W.A. (2008) Synthesis and in vitro activity of 1-(2,3-dichlorophenyl)-N-(pyridin-3-ylmethyl)-1H-1,2,4-triazol-5-amine and 4-(2,3-dichlorophenyl)-N-(pyridin-3-ylmethyl)-4H-1,2,4-triazol-3-amine P2X7 antagonists. Bioorg Med Chem Lett;18:20892092.
  • 19
    Chakravarty P.K., Zuegner L.L., Parsons W.H., Palucki B., Zhou B., Park M.K., Fisher M.H. Biaryl substituted triazoles as sodium channel blockers. U.S. Patent 7,572,822.
  • 20
    Alberto D.Z., Nadine J., Maria Pillar G.J., Maria Rosa C.A., Jose C.M. 1,2,4-Triazole derivatives as sigma receptor inhibitors. European Patent 1,921,073.
  • 21
    Jagerovic N., Hernandez-Folgado L., Alkorta I., Goya P., Navarro M., Serrano A., de Fonseca F.R., Dannert M.T., Alsasua A., Suardiaz M., Pascual D., Martin M.I. (2004) Discovery of 5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-3-hexyl-1h-1,2,4-triazole, a novel in vivo cannabinoid antagonist containing a 1,2,4-triazole motif. J Med Chem;47:29392942.
  • 22
    Lange J.H., van Stuivenberg H.H., Coolen H.K., Adolfs T.J., McCreary A.C., Keizer H.G., Wals H.C., Veerman W., Borst A.J., de Looff W., Verveer P.C., Kruse C.G. (2005) Bioisosteric replacements of the pyrazole moiety of rimonabant: synthesis, biological properties, and molecular modeling investigations of thiazoles, triazoles, and imidazoles as potent and selective CB1 cannabinoid receptor antagonists. J Med Chem;48:18231838.
  • 23
    Dunham N.W., Miya T.S. (1957) A note on a simple apparatus for detecting neurological deficit in rats and mice. J Am Pharm Assoc Am Pharm Assoc (Baltim);46:208209.
  • 24
    Siegmund E.A., Cadmus R.A. (1957) A method for evaluating both non-narcotic and narcotic analgesics. Proc Soc Exp Biol;95:729731.
  • 25
    Hunskaar S., Hole K. (1987) The formalin test in mice: dissociation between inflammatory and non-inflammatory pain. Pain;30:103114.
  • 26
    Bennett G.J., Xie Y.K. (1988) A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain;33:87107.
  • 27
    Seltzer Z., Dubner R., Shir Y. (1990) A novel behavioral model of neuropathic pain disorders produced in rats by partial sciatic nerve injury. Pain;43:205218.
  • 28
    Garth T., Whiteside J.H., Jamie B., Lilly M., Michelle P., Susan G., Katharine W. (2004) Pharmacological characterisation of a rat model of incisional pain. Br J Pharmacol;141:8591.
  • 29
    Harris J.M., Spencer P.S.J. (1962) A modified plethysmographic apparatus for recording volume changes in the rat paw. Pharm Pharmacol;14:464466.
  • 30
    Sekut L., Yarnall D., Stimpson S.A., Noel L.S., Bateman-Fite R., Clark R.L., Brackeen M.F., Menius J.A. Jr, Connolly K.A. (1995) Anti-inflammatory activity of phosphodiesterase (PDE)-IV inhibitors in acute and chronic models of inflammation. Clin Exp Immunol;100:126132.
  • 31
    Choi Y., Yoon Y.W., Na H.S., Kim S.H., Chung J.M. (1994) Behavioral signs of ongoing pain and cold allodynia in a rat model of neuropathic pain. Pain;59:369376.
  • 32
    Eliav E., Herzberg U., Ruda M.A., Bennett G.J. (1999) Neuropathic pain from an experimental neuritis of the rat sciatic nerve. Pain;83:169182.
  • 33
    Fairbanks C.A., Nguyen H.O., Grocholski B.M., Wilcox G.L. (2000) Moxonidine, a selective imidazoline-alpha2 -adrenergic receptor agonist, produces spinal synergistic antihyperalgesia with morphine in nerve-injured mice. Anesthesiology;93:765773.
  • 34
    Caudle R.M., Mannes A.J., Benoliel R., Eliav E., Iadarola M.J. (2001) Intrathecally administered cholera toxin blocks allodynia and hyperalgesia in persistent pain models. J Pain;2:118127.
  • 35
    Randall L.O., Selitto J.J. (1957) A method for measurement of analgesic activity on inflamed tissue. Arch Int Pharmacodyn Ther;111:409419.
  • 36
    Mellors A., Tappel A.J. (1966) The inhibition of mitochondrial peroxidation by ubiquinone and ubiquinol. Biol Chem;241:43534356.
  • 37
    Coderre T.J., Melzack R.J. (1992) The contribution of excitatory amino acids to central sensitization and persistent nociception after formalin-induced tissue injury. J Neurosci;12:36653670.
  • 38
    Chaplan S.R., Malmberg A.B., Yaksh T.L. (1997) Efficacy of spinal NMDA receptor antagonism in formalin hyperalgesia and nerve injury evoked allodynia in the rat. J Pharmacol Exp Ther;280:829838.
  • 39
    Okuda K., Sakurada C., Takahashi M., Yamada T., Sakurada T. (2001) Characterization of nociceptive responses and spinal releases of nitric oxide metabolites and glutamate evoked by different concentrations of formalin in rats. Pain;92:107115.
  • 40
    da Silva K.A., Manjavachi M.N., Paszcuk A.F., Pivatto M., Viegas C. Jr, Bolzani V.S., Calixto J.B. (2011) Plant derived alkaloid (-)-cassine induces anti-inflammatory and anti-hyperalgesics effects in both acute and chronic inflammatory and neuropathic pain models. Neuropharmacology;62:967977.